CCCC
Price
$2.72
Change
+$0.05 (+1.87%)
Updated
Sep 5 closing price
Capitalization
193.58M
53 days until earnings call
NWBO
Price
$0.25
Change
-$0.01 (-3.85%)
Updated
Sep 5 closing price
Capitalization
374.47M
Interact to see
Advertisement

CCCC vs NWBO

Header iconCCCC vs NWBO Comparison
Open Charts CCCC vs NWBOBanner chart's image
C4 Therapeutics
Price$2.72
Change+$0.05 (+1.87%)
Volume$1.41M
Capitalization193.58M
Northwest Biotherapeutics
Price$0.25
Change-$0.01 (-3.85%)
Volume$4.86M
Capitalization374.47M
CCCC vs NWBO Comparison Chart in %
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NWBO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. NWBO commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and NWBO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (CCCC: $2.72 vs. NWBO: $0.25)
Brand notoriety: CCCC and NWBO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 91% vs. NWBO: 144%
Market capitalization -- CCCC: $193.58M vs. NWBO: $374.47M
CCCC [@Biotechnology] is valued at $193.58M. NWBO’s [@Biotechnology] market capitalization is $374.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileNWBO’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • NWBO’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than NWBO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 3 TA indicator(s) are bullish while NWBO’s TA Score has 6 bullish TA indicator(s).

  • CCCC’s TA Score: 3 bullish, 5 bearish.
  • NWBO’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NWBO is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а +4.62% price change this week, while NWBO (@Biotechnology) price change was -16.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

CCCC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NWBO($374M) has a higher market cap than CCCC($194M). NWBO YTD gains are higher at: -8.055 vs. CCCC (-24.444). NWBO has higher annual earnings (EBITDA): -72.28M vs. CCCC (-109.63M). CCCC has more cash in the bank: 215M vs. NWBO (4.32M). CCCC has less debt than NWBO: CCCC (62.9M) vs NWBO (69.8M). CCCC has higher revenues than NWBO: CCCC (34.2M) vs NWBO (1.09M).
CCCCNWBOCCCC / NWBO
Capitalization194M374M52%
EBITDA-109.63M-72.28M152%
Gain YTD-24.444-8.055303%
P/E RatioN/AN/A-
Revenue34.2M1.09M3,126%
Total Cash215M4.32M4,981%
Total Debt62.9M69.8M90%
FUNDAMENTALS RATINGS
NWBO: Fundamental Ratings
NWBO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCNWBO
RSI
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 10 days ago
79%
Declines
ODDS (%)
Bearish Trend 19 days ago
89%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NWBO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMEAX13.450.18
+1.36%
Ashmore Emerging Markets Equity A
CDGRX13.000.02
+0.15%
Copeland Dividend Growth Fund Class A
BMSYX15.50N/A
N/A
MFS Blended Research Mid Cap Eq R6
MRFIX65.61-0.22
-0.33%
MFS Research I
MDLVX30.51-0.10
-0.33%
BlackRock Advantage Large Cap Val Inv A

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+1.87%
BEAM - CCCC
46%
Loosely correlated
+12.62%
SYRE - CCCC
44%
Loosely correlated
+0.06%
OCUL - CCCC
44%
Loosely correlated
+7.09%
MGNX - CCCC
43%
Loosely correlated
+3.09%
KYMR - CCCC
43%
Loosely correlated
+3.10%
More

NWBO and

Correlation & Price change

A.I.dvisor tells us that NWBO and CCCC have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NWBO and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NWBO
1D Price
Change %
NWBO100%
-2.84%
CCCC - NWBO
24%
Poorly correlated
+1.87%
CBUS - NWBO
23%
Poorly correlated
+1.59%
XERS - NWBO
23%
Poorly correlated
-0.51%
GLUE - NWBO
22%
Poorly correlated
+0.61%
VRTX - NWBO
21%
Poorly correlated
-0.20%
More